Byonyks
PrivateLast Round
Early Funding
Oct 14, 2024
Total Funding Raised
$11.37M
Company Overview
Byonyks is a medical device company that develops and manufactures home-based automated peritoneal dialysis (APD) systems for patients with kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Byonyks Comparables
Compare Byonyks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nextkidney | 83% | |
| Vivance | 81% | |
| Baxter International Inc | 79% | |
Byonyks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 14, 2024 | ||||
| Seed | Sep 3, 2020 |
Key People
Founding team and executive leadership
Byonyks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ignite National Technology Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors increased 1662% MoM to 6.8K.
- Oct 14, 2024
$9M raised in early funding.
Byonyks Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Byonyks's valuation, stock price, and market status.